抑制剂:
δENaC, γENaC, 11β-HSD2, 3110007F17Rik, 4922502D21Rik, 4930428D18Rik, 4933425O20Rik, 5430405G05Rik, AE3, Aldosterone, Angiogenesis, AQP12A, AQP2, ATP13A3, ATPase, C20orf111, C4ST-2, C8orf5, Calcium Channel Protein, CAT-4, CatSperγ, Cdc50B, CL-P1, CNG-1, COMMD3, CTA, EG639396, EG668210, ENDOD1, FAM18B, FXYD7, GPR89B, HEAB, ILDR1, Like-Sm (LSm), LRRC8E, LTRPC7, Ly6/uPAR (LYNX; Ly6/neurotoxin), mKIAA0195, MMGT1, MrgA9, MrgB3, Na+ CP type XIα, Na+/K+-ATPase α1, Neurophysin I, NHE, NHE-3, NHE-4, NHE-5, NHE-7, NHE-9, NKAIN3, NKAIN4, NOP9, Olfr31, Olfr33, Olfr332, Olr1432, Olr34, Olr444, OR10AG1, OR10H5, OR4D10, OR52E5, OR5K4, OR8U9, OSR1, OTOP1, OTOP2, OTOP3, P5CRL, PEPT1, Polycystin-2, Polycystin-L, PQLC2, Prostasin, PRPF39, rBAT, SART-1, SFRS15, SLAM, SLC10A4, SLC5 (solute carrier family 5; SLC5A), SNAT3, Sodium Channel Protein, Sodium/Potassium-ATPase Protein, spectrin αII, STOML1, STOML3, TAS1R (taste receptor; GPCR), TAX-4, THEM92, TMEM143, TMEM150A, TMEM168, Tmem210, TMEM215, TMEM34, TMEM63B, TMEM86A, TMEM87B, TMIE, Trk1, Unc79, uPA, V1RB5, V1RI2, Vmn2r2, Vmn2r31, Vmn2r39, Vmn2r4, Vmn2r55, Vmn2r80, Vmn2r81, WNK1, WNK3, Xg, 和 ZNHIT2.